why choose us

First received: February 08, 2023

Clinical Trial: A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms

Study Status: Completed

Recruit Status: RECRUITING

Condition: Relapsed or Refractory Acute Myeloid Leukemia

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-Label, Safety, Tolerability, And Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms

Brief Summary: This is an open-label, non-randomized, Phase 1 study to determine the safety and tolerability of NC525.This study will also assess the clinical benefit in subjects with advanced myeloid neoplasms.

Read more